Reuters logo
5 months ago
BRIEF-Oncodesign says option to license rights for Parkinson Program from Ipsen
March 15, 2017 / 5:34 PM / 5 months ago

BRIEF-Oncodesign says option to license rights for Parkinson Program from Ipsen

March 15 (Reuters) - Oncodesign Sa

* Oncodesign announces return of research collaboration and option to license rights for parkinson program from Ipsen

* Oncodesign recovers full rights to LRRK2 program and patent portfolio

* Following reacquisition, Oncodesign now intends to pursue further development of LRRK2 based parkinson program internally Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below